Quality of Life is assessed prospectively with the internationally established and validated questionnaires of the European Organization for Research and Treatment of Cancer (EORTC; http://groups.eortc.be/qol). The basic module EORTC QLQ-C30 is of general use for all cancer sites and consists of five functional scales (physical, emotional, social, role and cognitive functioning), a global health status/QoL scale and several symptom scales commonly reported by cancer patients. The cervical cancer module EORTC QLQ-CX24 covers typical disease and treatment related symptoms and items regarding sexuality.  In addition, 6 clinically relevant items of the endometrial module EORTC EN-24 are added. The time points of assessment are scheduled according to the morbidity assessment.

Please note that QOL assessment is mandatory in the EMBRACE II study.

Before start of treatment

 

Baseline

 

 

 

During treatment

Week 4

Early morbidity

End of treatment

End of treatment

 

1st year

3, 6, 9, 12 months

Late morbidity

2nd year

18, 24 months

3rd year

30, 36 months

4th year

48 months

5th year

60 months

 

The EORTC QLQ modules are available in the following languages:

Language

EORTC QLQ-C30

EORTC QLQ-CX24

EORTC QLQ-EN24

Azerbaijani

No

No

No

Chinese Cantonese (HK)

Yes

Yes

Yes

Croatian

Yes

Yes

Yes

Danish

Yes

Yes

Yes

Dutch

Yes

Yes

Yes

English

Yes

Yes

Yes

Estonian

Yes

No

No

French

Yes

Yes

Yes

German

Yes

Yes

Yes

Hindi/Marathi

Yes

Yes

No

Hungarian

Yes

No

Yes

Italian

Yes

Yes

Yes

Norwegian

Yes

Yes

Yes

Polish

Yes

Yes

Yes

Slovakian

Yes

No

No

Slovenian

Yes

No

No

Spanish

Yes

Yes

Yes

Swedish

Yes

Yes

Yes

Thai

Yes

No

Yes


All modules can be downloaded here.


If you need a specific language in your center that is not yet available, please contact the EMBRACE study office (tamara.rumpold@meduniwien.ac.at) to discuss your options.

 

An interim report of Quality of Life within the EMBRACE I study is available here.





Participation and Tools


Go to Embrace I

Already 500 patients!

So many new patients despite summer time
Read more...

400 patients enrolled in EMBRACE II

A new milestone has been reached
Read more...